Literature DB >> 16210131

C4d staining of pulmonary allograft biopsies: an immunoperoxidase study.

W Dean Wallace1, Elaine F Reed, David Ross, Charles R Lassman, Michael C Fishbein.   

Abstract

BACKGROUND: The role of antibody-mediated/humoral rejection in lung allografts is not fully elucidated. In other organ systems, deposition of a specific complement product, C4d, is a sensitive and specific marker for humoral rejection. C4d can be evaluated in tissue biopsies by immunofluorescence or light microscopic immunohistochemical staining techniques. Using immunohistochemical staining techniques we sought to determine whether there was any specific staining pattern for C4d in lung allograft biopsies with or without the diagnosis of acute or chronic cellular or humoral rejection.
METHODS: A total of 68 lung transplant biopsies, performed at UCLA Medical Center from January 2002 to August 2004, were collected and the paraffin blocks were re-cut and stained for C4d by an immunoperoxidase technique. The cases were separated by the presence or absence of features of acute and/or chronic rejection based on the International Society for Heart and Lung Transplantation working formulation for the classification of pulmonary allograft rejection, revised 1995. The pattern of staining for C4d was then systematically examined.
RESULTS: Positive staining in a variable, focal non-specific pattern was observed. There was no consistent staining pattern within the different diagnostic groups.
CONCLUSIONS: C4d staining of paraffin-embedded lung allograft biopsies, using currently available techniques, does not identify acute or chronic cellular or humoral rejection in lung allograft tissue.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16210131     DOI: 10.1016/j.healun.2004.11.038

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  13 in total

Review 1.  Pros and cons for C4d as a biomarker.

Authors:  Danielle Cohen; Robert B Colvin; Mohamed R Daha; Cinthia B Drachenberg; Mark Haas; Volker Nickeleit; Jane E Salmon; Banu Sis; Ming-Hui Zhao; Jan A Bruijn; Ingeborg M Bajema
Journal:  Kidney Int       Date:  2012-02-01       Impact factor: 10.612

2.  Increased erythrocyte C4D is associated with known alloantibody and autoantibody markers of antibody-mediated rejection in human lung transplant recipients.

Authors:  Angali Golocheikine; Dilip S Nath; Haseeb Ilias Basha; Deepti Saini; Donna Phelan; Aviva Aloush; Elbert P Trulock; Ramsey R Hachem; G Alexander Patterson; Joseph M Ahearn; Thalachallour Mohanakumar
Journal:  J Heart Lung Transplant       Date:  2010-04       Impact factor: 10.247

Review 3.  Bronchiolitis obliterans syndrome: the Achilles' heel of lung transplantation.

Authors:  S Samuel Weigt; Ariss DerHovanessian; W Dean Wallace; Joseph P Lynch; John A Belperio
Journal:  Semin Respir Crit Care Med       Date:  2013-07-02       Impact factor: 3.119

4.  Role of complement activation in obliterative bronchiolitis post-lung transplantation.

Authors:  Hidemi Suzuki; Mark E Lasbury; Lin Fan; Ragini Vittal; Elizabeth A Mickler; Heather L Benson; Rebecca Shilling; Qiang Wu; Daniel J Weber; Sarah R Wagner; Melissa Lasaro; Denise Devore; Yi Wang; George E Sandusky; Kelsey Lipking; Pankita Pandya; John Reynolds; Robert Love; Thomas Wozniak; Hongmei Gu; Krista M Brown; David S Wilkes
Journal:  J Immunol       Date:  2013-09-16       Impact factor: 5.422

5.  Pathologic findings in lung allografts with anti-HLA antibodies.

Authors:  Matthew M DeNicola; Sam S Weigt; John A Belperio; Elaine F Reed; David J Ross; W Dean Wallace
Journal:  J Heart Lung Transplant       Date:  2013-01-10       Impact factor: 10.247

6.  C4d deposition and cellular infiltrates as markers of acute rejection in rat models of orthotopic lung transplantation.

Authors:  Kazunori Murata; Takekazu Iwata; Shinji Nakashima; Karen Fox-Talbot; Zhiping Qian; David S Wilkes; William M Baldwin
Journal:  Transplantation       Date:  2008-07-15       Impact factor: 4.939

7.  IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants.

Authors:  William J Burlingham; Robert B Love; Ewa Jankowska-Gan; Lynn D Haynes; Qingyong Xu; Joseph L Bobadilla; Keith C Meyer; Mary S Hayney; Ruedi K Braun; Daniel S Greenspan; Bagavathi Gopalakrishnan; Junchao Cai; David D Brand; Shigetoshi Yoshida; Oscar W Cummings; David S Wilkes
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

Review 8.  Acute rejection and humoral sensitization in lung transplant recipients.

Authors:  Tereza Martinu; Dong-Feng Chen; Scott M Palmer
Journal:  Proc Am Thorac Soc       Date:  2009-01-15

Review 9.  Complement-mediated microvascular injury leads to chronic rejection.

Authors:  Mohammad A Khan; Mark R Nicolls
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

10.  Mechanisms of complement activation, C4d deposition, and their contribution to the pathogenesis of antibody-mediated rejection.

Authors:  Kazunori Murata; William M Baldwin
Journal:  Transplant Rev (Orlando)       Date:  2009-04-10       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.